Autonomix Medical Amends 10-K, Confirms Compliance Status
Ticker: AMIX · Form: 10-K/A · Filed: Jul 28, 2025 · CIK: 1617867
Sentiment: neutral
Topics: 10-K/A, SEC Filing, Regulatory Compliance, Medical Devices, Annual Report Amendment, Nasdaq, Corporate Governance
Related Tickers: AMIX
TL;DR
**Autonomix Medical's 10-K/A is a procedural update, not a game-changer, but solidifies its regulatory footing, which is a quiet positive for stability.**
AI Summary
Autonomix Medical, Inc. (AMIX) filed a 10-K/A on July 28, 2025, for the fiscal year ended March 31, 2025, indicating an amendment to its annual report. The filing confirms the company is not a well-known seasoned issuer and is not exempt from filing reports under Section 13 or 15(d) of the Securities Exchange Act of 1934. Autonomix Medical has filed all required reports during the preceding 12 months and has been subject to filing requirements for the past 90 days. The company also confirmed electronic submission of all Interactive Data Files as required by Rule 405 of Regulation S-T. As a surgical and medical instruments and apparatus company, AMIX operates in a highly regulated and competitive sector. The amendment itself does not provide specific financial figures for revenue or net income, but rather updates regulatory compliance and company status. The strategic outlook remains focused on navigating regulatory landscapes and maintaining reporting compliance, which is crucial for a company with a Nasdaq listing under the trading symbol AMIX.
Why It Matters
This 10-K/A filing by Autonomix Medical, Inc. is significant for investors as it clarifies the company's regulatory standing and compliance with SEC reporting requirements, including the submission of Interactive Data Files. While not revealing new financial data, it assures the market of the company's adherence to transparency, which is foundational for investor confidence. For employees and customers, consistent regulatory compliance signals operational stability. In a competitive medical device market, maintaining a clean regulatory record is crucial for Autonomix Medical to attract capital and maintain its Nasdaq listing, differentiating it from less compliant peers.
Risk Assessment
Risk Level: low — The risk level is low because the 10-K/A filing primarily addresses administrative and compliance matters, confirming Autonomix Medical has met its reporting obligations. There are no indications of new financial distress, operational setbacks, or significant changes in business strategy within this amendment. The filing explicitly states the company has filed all required reports and submitted Interactive Data Files, reducing regulatory compliance risk.
Analyst Insight
Investors should view this 10-K/A as a confirmation of Autonomix Medical's ongoing regulatory compliance, not a catalyst for immediate trading action. It reinforces the company's foundational stability, allowing investors to focus on future operational and financial disclosures for investment decisions.
Key Numbers
- 001-41940 — Commission File Number (Identifies Autonomix Medical's filings with the SEC)
- 47-1607810 — I.R.S. Employer Identification No. (Unique tax identification for Autonomix Medical)
- 832-277-7816 — Business Phone Number (Contact number for Autonomix Medical)
Key Players & Entities
- Autonomix Medical, Inc. (company) — Registrant and filer of the 10-K/A
- SEC (regulator) — United States Securities and Exchange Commission
- Nasdaq Stock Market (company) — Exchange where AMIX Common Stock is registered
- 001-41940 (regulator) — Commission File Number for Autonomix Medical, Inc.
- March 31, 2025 (date) — Fiscal year end for the reported period
- July 28, 2025 (date) — Filing date of the 10-K/A
- The Woodlands, Texas (company) — Location of Autonomix Medical's principal executive offices
- Delaware (company) — State of incorporation for Autonomix Medical, Inc.
FAQ
What is the purpose of Autonomix Medical's 10-K/A filing?
Autonomix Medical's 10-K/A filing is an amendment to its annual report for the fiscal year ended March 31, 2025, primarily to update and confirm its regulatory compliance status, including the submission of all required reports and Interactive Data Files.
Did Autonomix Medical report new financial results in this 10-K/A?
No, the 10-K/A filing by Autonomix Medical does not contain new financial results such as revenue or net income. It focuses on administrative and compliance updates to the previously filed annual report.
Is Autonomix Medical considered a well-known seasoned issuer?
No, Autonomix Medical, Inc. explicitly indicated in its 10-K/A filing that it is not a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Has Autonomix Medical filed all required SEC reports?
Yes, Autonomix Medical confirmed in its 10-K/A that it has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months.
What is Autonomix Medical's trading symbol and where is it listed?
Autonomix Medical's trading symbol is AMIX, and its Common Stock, with a $0.001 par value, is registered on The Nasdaq Stock Market.
What is the fiscal year end for Autonomix Medical, Inc.?
The fiscal year end for Autonomix Medical, Inc. is March 31, as indicated by the 'For the fiscal year ended March 31, 2025' statement in the 10-K/A.
Where are Autonomix Medical's principal executive offices located?
Autonomix Medical's principal executive offices are located at 21 Waterway Avenue, Suite 300, The Woodlands, Texas 77380.
What industry does Autonomix Medical operate in?
Autonomix Medical, Inc. operates in the Surgical & Medical Instruments & Apparatus industry, classified under SIC code 3841.
Did Autonomix Medical submit Interactive Data Files as required?
Yes, Autonomix Medical confirmed in its 10-K/A that it has submitted electronically every Interactive Data File required pursuant to Rule 405 of Regulation S-T during the preceding 12 months.
What is the significance of the 10-K/A for Autonomix Medical investors?
For Autonomix Medical investors, the 10-K/A signifies the company's commitment to regulatory transparency and compliance, which is a positive signal for corporate governance and foundational stability, even without new financial disclosures.
Industry Context
Autonomix Medical operates in the Surgical & Medical Instruments & Apparatus industry (SIC 3841), a sector characterized by high regulatory scrutiny and intense competition. Companies in this space must navigate complex approval processes and rapidly evolving technological advancements to bring innovative products to market.
Regulatory Implications
As a medical device company, Autonomix Medical is subject to stringent regulations from bodies like the FDA. The company's confirmation of filing all required reports and submitting Interactive Data Files electronically highlights its commitment to regulatory compliance, which is critical for maintaining its Nasdaq listing and investor confidence.
What Investors Should Do
- Review the specific amendments in the 10-K/A filing.
- Monitor future SEC filings for detailed financial performance.
- Assess the company's compliance with Nasdaq listing requirements.
Key Dates
- 2025-03-31: Fiscal Year End — Marks the end of the reporting period for the annual financial statements.
- 2025-07-28: 10-K/A Filing — Amendment to the annual report, indicating updates or corrections to the previously filed 10-K.
Glossary
- 10-K/A
- An amended annual report filed with the SEC to correct or supplement information in a previously filed 10-K. (This filing is an amendment to Autonomix Medical's annual report, indicating a need for updates or corrections.)
- Well-known seasoned issuer
- A company that meets certain size and reporting history requirements, allowing for streamlined registration of securities. (Autonomix Medical is explicitly stated as not being a well-known seasoned issuer, which can impact its filing flexibility.)
- Regulation S-T
- SEC regulation governing the electronic submission of filings, including requirements for Interactive Data Files (XBRL). (The company confirmed compliance with electronic submission of Interactive Data Files, a key aspect of modern SEC reporting.)
- SIC Code 3841
- Standard Industrial Classification code for Surgical & Medical Instruments & Apparatus. (This code categorizes Autonomix Medical's business operations within the medical device industry.)
Year-Over-Year Comparison
This filing is an amendment (10-K/A) to the annual report for the fiscal year ended March 31, 2025. As such, it primarily serves to correct or supplement information from a prior filing rather than present new year-over-year financial comparisons. The amendment confirms the company's status as a non-seasoned issuer and its compliance with filing requirements over the past 12 months and 90 days, including electronic data submissions.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on July 28, 2025 regarding Autonomix Medical, Inc. (AMIX).